Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast agents accumulate in tissues inside patients. This has raised concern because prolonged, elevated levels of gadolinium in the body may cause a nephrogenic systemic fibrosis in patients with severe kidney disease. Adding to this concern were three studies in 2015, which raised new gadolinium safety concerns after it was found the agent also accumulates in the brain
New contrast injection strategies for low kV and keV imaging • APPLIED RADIOLOGY
Switch to MR Angiography for PE Mitigated Impact of Recent Contrast Shortage
Contrast Media Imaging Technology News
Gadolinium Contrast Media Market With Highly Productive Segment To Expand Outstandingly
Alternatives To Gadolinium – RS2D
Imaging Technology News - Magnetic Resonance Imaging (MRI)
ITN Wins Jesse H. Neal Award for Best Technical Content
History and Basic Principles of Echo-Contrast Media - A J Hindle, A C Perkins, 1995
CONTRAST MEDIA TERMS Crossword - WordMint
MRI's Environmental Impact
Contrast Media/Contrast Agents Market Demand & Future Scope Including Top Players by rohit sohel - Issuu
ACR Changes CT and MRI Accreditation Contrast Media Supervision Requirements - AHEConline Blog
Global Contrast Media Shortage Means Urgent Changes in Interventional Radiology Practices
New Study Informs Mitigation Strategies for Contrast Shortage in CT by Identifying Promising Areas of Focus